Literature DB >> 27864369

Structures of the Multidrug Transporter P-glycoprotein Reveal Asymmetric ATP Binding and the Mechanism of Polyspecificity.

Lothar Esser1, Fei Zhou1, Kristen M Pluchino1, Joseph Shiloach2, Jichun Ma1, Wai-Kwan Tang1, Camilo Gutierrez1, Alex Zhang1, Suneet Shukla1, James P Madigan1, Tongqing Zhou3, Peter D Kwong3, Suresh V Ambudkar1, Michael M Gottesman1, Di Xia4.   

Abstract

P-glycoprotein (P-gp) is a polyspecific ATP-dependent transporter linked to multidrug resistance in cancer; it plays important roles in determining the pharmacokinetics of many drugs. Understanding the structural basis of P-gp, substrate polyspecificity has been hampered by its intrinsic flexibility, which is facilitated by a 75-residue linker that connects the two halves of P-gp. Here we constructed a mutant murine P-gp with a shortened linker to facilitate structural determination. Despite dramatic reduction in rhodamine 123 and calcein-AM transport, the linker-shortened mutant P-gp possesses basal ATPase activity and binds ATP only in its N-terminal nucleotide-binding domain. Nine independently determined structures of wild type, the linker mutant, and a methylated P-gp at up to 3.3 Å resolution display significant movements of individual transmembrane domain helices, which correlated with the opening and closing motion of the two halves of P-gp. The open-and-close motion alters the surface topology of P-gp within the drug-binding pocket, providing a mechanistic explanation for the polyspecificity of P-gp in substrate interactions.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ABC transporter; ATP-binding; ATPase; P-glycoprotein; asymmetry; crystal structure; glycoprotein; multidrug transporter; polyspecificity; structure

Mesh:

Substances:

Year:  2016        PMID: 27864369      PMCID: PMC5241723          DOI: 10.1074/jbc.M116.755884

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance.

Authors:  M Azzaria; E Schurr; P Gros
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

2.  Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein.

Authors:  S Dey; M Ramachandra; I Pastan; M M Gottesman; S V Ambudkar
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

3.  Cross-linking of human multidrug resistance P-glycoprotein by the substrate, tris-(2-maleimidoethyl)amine, is altered by ATP hydrolysis. Evidence for rotation of a transmembrane helix.

Authors:  T W Loo; D M Clarke
Journal:  J Biol Chem       Date:  2001-06-27       Impact factor: 5.157

4.  Drug-stimulated ATPase activity of human P-glycoprotein requires movement between transmembrane segments 6 and 12.

Authors:  T W Loo; D M Clarke
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

5.  Characterization of the azidopine and vinblastine binding site of P-glycoprotein.

Authors:  E P Bruggemann; S J Currier; M M Gottesman; I Pastan
Journal:  J Biol Chem       Date:  1992-10-15       Impact factor: 5.157

6.  Mechanism of action of human P-glycoprotein ATPase activity. Photochemical cleavage during a catalytic transition state using orthovanadate reveals cross-talk between the two ATP sites.

Authors:  C A Hrycyna; M Ramachandra; S V Ambudkar; Y H Ko; P L Pedersen; I Pastan; M M Gottesman
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

7.  Characterization of an asymmetric occluded state of P-glycoprotein with two bound nucleotides: implications for catalysis.

Authors:  Alena Siarheyeva; Ronghua Liu; Frances J Sharom
Journal:  J Biol Chem       Date:  2010-01-08       Impact factor: 5.157

8.  Mutations in intracellular loops 1 and 3 lead to misfolding of human P-glycoprotein (ABCB1) that can be rescued by cyclosporine A, which reduces its association with chaperone Hsp70.

Authors:  Khyati Kapoor; Jaya Bhatnagar; Eduardo E Chufan; Suresh V Ambudkar
Journal:  J Biol Chem       Date:  2013-09-24       Impact factor: 5.157

Review 9.  ABC transporters: a riddle wrapped in a mystery inside an enigma.

Authors:  Peter M Jones; Megan L O'Mara; Anthony M George
Journal:  Trends Biochem Sci       Date:  2009-09-11       Impact factor: 13.807

10.  On the origin of large flexibility of P-glycoprotein in the inward-facing state.

Authors:  Po-Chao Wen; Brandy Verhalen; Stephan Wilkens; Hassane S Mchaourab; Emad Tajkhorshid
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

View more
  66 in total

1.  Structural Insights into the Lipid A Transport Pathway in MsbA.

Authors:  Pius S Padayatti; Sung Chang Lee; Robyn L Stanfield; Po-Chao Wen; Emad Tajkhorshid; Ian A Wilson; Qinghai Zhang
Journal:  Structure       Date:  2019-05-23       Impact factor: 5.006

Review 2.  Hydrogen-deuterium exchange mass spectrometry of membrane proteins in lipid nanodiscs.

Authors:  Michelle Redhair; Amanda F Clouser; William M Atkins
Journal:  Chem Phys Lipids       Date:  2019-02-22       Impact factor: 3.329

Review 3.  Pharmacological analysis of CFTR variants of cystic fibrosis using stem cell-derived organoids.

Authors:  Kevin G Chen; Pingyu Zhong; Wei Zheng; Jeffrey M Beekman
Journal:  Drug Discov Today       Date:  2019-06-04       Impact factor: 7.851

4.  The FLT3 inhibitor midostaurin selectively resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.

Authors:  Sung-Han Hsiao; Sabrina Lusvarghi; Yang-Hui Huang; Suresh V Ambudkar; Sheng-Chieh Hsu; Chung-Pu Wu
Journal:  Cancer Lett       Date:  2019-01-11       Impact factor: 8.679

5.  Structural insight into substrate and inhibitor discrimination by human P-glycoprotein.

Authors:  Amer Alam; Julia Kowal; Eugenia Broude; Igor Roninson; Kaspar P Locher
Journal:  Science       Date:  2019-02-15       Impact factor: 47.728

6.  Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines.

Authors:  Chung-Pu Wu; Sabrina Lusvarghi; Jyun-Cheng Wang; Sung-Han Hsiao; Yang-Hui Huang; Tai-Ho Hung; Suresh V Ambudkar
Journal:  Mol Pharm       Date:  2019-06-04       Impact factor: 4.939

7.  ATP-dependent thermostabilization of human P-glycoprotein (ABCB1) is blocked by modulators.

Authors:  Sabrina Lusvarghi; Suresh V Ambudkar
Journal:  Biochem J       Date:  2019-12-19       Impact factor: 3.857

8.  Conformational dynamics of P-glycoprotein in lipid nanodiscs and detergent micelles reveal complex motions on a wide time scale.

Authors:  Mavis Jiarong Li; Miklos Guttman; William M Atkins
Journal:  J Biol Chem       Date:  2018-03-06       Impact factor: 5.157

9.  Global alteration of the drug-binding pocket of human P-glycoprotein (ABCB1) by substitution of fifteen conserved residues reveals a negative correlation between substrate size and transport efficiency.

Authors:  Shahrooz Vahedi; Eduardo E Chufan; Suresh V Ambudkar
Journal:  Biochem Pharmacol       Date:  2017-07-17       Impact factor: 5.858

10.  Vasohibin 1 inhibits Adriamycin resistance in osteosarcoma cells via the protein kinase B signaling pathway.

Authors:  Wei Huang; Yangguang Ren; Hui Liu
Journal:  Oncol Lett       Date:  2018-02-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.